61830-41-9

Basic information

• Product Name: 2-Pyridinecarboxylic acid, 3,5-dibroMo-, Methyl ester
• Synonyms: 2-Pyridinecarboxylic acid, 3,5-dibroMo-, Methyl ester;Methyl 3,5-DibroMopicolinate;JZYLJXUFYOEGFU-UHFFFAOYSA-N
• CAS NO: 61830-41-9
• Molecular Formula: C₇H₅Br₂NO₂
• Molecular Weight: 294.9281
• Mol File: 61830-41-9.mol
• Article Data: 2

Chemical Properties

• Melting Point: 96-97 °C
• Boiling Point: 321.4°C at 760 mmHg
• Flash Point: 148.2°C
• Appearance: /
• Density: 1.928g/cm³
• Vapor Pressure: 0.000299mmHg at 25°C
• Refractive Index: 1.588
• PKA: -3.26±0.10(Predicted)
• CAS DataBase Reference: 2-Pyridinecarboxylic acid, 3,5-dibroMo-, Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Pyridinecarboxylic acid, 3,5-dibroMo-, Methyl ester(61830-41-9)
• EPA Substance Registry System: 2-Pyridinecarboxylic acid, 3,5-dibroMo-, Methyl ester(61830-41-9)

Safety Data

• Hazardous Substances Data: 61830-41-9(Hazardous Substances Data)

Usage

InChI:InChI=1/C7H5Br2NO2/c1-12-7(11)6-5(9)2-4(8)3-10-6/h2-3H,1H3

Upstream product

• 67-56-1 methanol 
• 61830-40-8 3,5-dibromopyridine-2-carboxylic acid 
• 861019-41-2 3,5-dibromo-4-chloro-pyridine-2-carboxylic acid methyl ester 
• 698393-07-6 3,5-dibromo-4-chloro-pyridine-2-carboxylic acid 
• 858852-20-7 3,5-dibromo-4-hydroxy-pyridine-2-carboxylic acid 

Relevant articles and documents

COMBINATION PRODUCT FOR THE TREATMENT OF CANCEROUS DISEASES

The present invention relates to a product for combination therapies useful for the treatment of cancer diseases. In particular, the invention relates to the combination of an anti-PD-Ll antibody and an MCT4 inhibitor of Formula (I). The therapeutic combination may be utilized for the use in treating a subject having a cancer disease that tests positive for PD-L1 and/or MCT4 expression.